222 related articles for article (PubMed ID: 11836345)
1. Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.
Schwarz JM; Mulligan K; Lee J; Lo JC; Wen M; Noor MA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2002 Feb; 87(2):942. PubMed ID: 11836345
[TBL] [Abstract][Full Text] [Related]
2. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
3. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.
Christopher M; Hew FL; Oakley M; Rantzau C; Alford F
J Clin Endocrinol Metab; 1998 May; 83(5):1668-81. PubMed ID: 9589675
[TBL] [Abstract][Full Text] [Related]
4. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
Rao MN; Mulligan K; Tai V; Wen MJ; Dyachenko A; Weinberg M; Li X; Lang T; Grunfeld C; Schwarz JM; Schambelan M
J Clin Endocrinol Metab; 2010 Sep; 95(9):4361-6. PubMed ID: 20610601
[TBL] [Abstract][Full Text] [Related]
5. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
6. The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.
Beshyah SA; Henderson A; Niththyananthan R; Skinner E; Anyaoku V; Richmond W; Sharp P; Johnston DG
J Clin Endocrinol Metab; 1995 Feb; 80(2):356-63. PubMed ID: 7852490
[TBL] [Abstract][Full Text] [Related]
7. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
Segerlantz M; Bramnert M; Manhem P; Laurila E; Groop LC
Eur J Endocrinol; 2003 Dec; 149(6):511-9. PubMed ID: 14640991
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism.
Hannon TS; Danadian K; Suprasongsin C; Arslanian SA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3033-9. PubMed ID: 17519313
[TBL] [Abstract][Full Text] [Related]
10. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.
Schwarz JM; Noworolski SM; Wen MJ; Dyachenko A; Prior JL; Weinberg ME; Herraiz LA; Tai VW; Bergeron N; Bersot TP; Rao MN; Schambelan M; Mulligan K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2434-42. PubMed ID: 25825943
[TBL] [Abstract][Full Text] [Related]
11. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
[TBL] [Abstract][Full Text] [Related]
12. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection.
Schwarz JM; Neese RA; Turner S; Dare D; Hellerstein MK
J Clin Invest; 1995 Dec; 96(6):2735-43. PubMed ID: 8675642
[TBL] [Abstract][Full Text] [Related]
13. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
Van Pareren YK; De Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Drop SL
J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
[TBL] [Abstract][Full Text] [Related]
14. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis.
Gastaldelli A; Miyazaki Y; Pettiti M; Buzzigoli E; Mahankali S; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 2004 Aug; 89(8):3914-21. PubMed ID: 15292327
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
[TBL] [Abstract][Full Text] [Related]
16. Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
Wise S; Nielsen M; Rizza R
J Clin Endocrinol Metab; 1997 Jun; 82(6):1828-33. PubMed ID: 9177391
[TBL] [Abstract][Full Text] [Related]
17. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.
Bramnert M; Segerlantz M; Laurila E; Daugaard JR; Manhem P; Groop L
J Clin Endocrinol Metab; 2003 Apr; 88(4):1455-63. PubMed ID: 12679422
[TBL] [Abstract][Full Text] [Related]
19. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.
Møller N; Jørgensen JO
Endocr Rev; 2009 Apr; 30(2):152-77. PubMed ID: 19240267
[TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents.
Viganò A; Mora S; Manzoni P; Schneider L; Beretta S; Molinaro M; di Natale B; Brambilla P
J Clin Endocrinol Metab; 2005 Jul; 90(7):4075-80. PubMed ID: 15840750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
